Edwards Lifesciences Corporation Common Stock (EW)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 181% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 13.2% — below-average profitability
- Revenue growing at 12% annually
Edwards Lifesciences Corporation Common Stock (EW) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $50.1 billion . Key value metrics: P/E ratio 36.7, P/B ratio 4.85, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Edwards Lifesciences Corporation Common Stock — Fundamental Analysis Summary
Edwards Lifesciences Corporation Common Stock (EW) is currently trading 181% above its Graham Number of $30.91, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 36.7x.
On financial health, EW shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 13.2% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.06.
StockPik's composite Value Score for EW is 69/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EW reports a high gross margin of 78.0% (sector average: 39.4%) and a strong operating margin of 25.9%.
EW shows revenue growing at 12% year-over-year, with earnings declining at 74%.